Citius Pharmaceuticals Inc (CTXR) Stock Analysis

Citius Pharmaceuticals Inc (CTXR) is a publicly traded company in the HEALTHCARE sector. It trades at $0.60, carries a market capitalization of $17.40M. This page summarizes the public market data, fundamentals, and frequently asked questions for CTXR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Citius Pharmaceuticals Inc currently has a Bullish sentiment score of 0.26.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals, Inc. (CTXR) is a biopharmaceutical company headquartered in Cranford, New Jersey, that specializes in developing and commercializing innovative products for critical care settings. With a focus on addressing significant unmet medical needs, Citius boasts a promising pipeline of therapies aimed at improving patient outcomes in hospitals. The company's commitment to advancing healthcare is bolstered by its utilization of cutting-edge technology and strategic partnerships...

GNG Research Analysis

GNG Research scores Citius Pharmaceuticals Inc (CTXR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CTXR.

Frequently Asked Questions

Does CTXR pay dividends?

Citius Pharmaceuticals Inc (CTXR) does not currently pay a regular dividend.

What is CTXR's market cap?

Citius Pharmaceuticals Inc (CTXR) has a market capitalization of $17.40M with a current stock price of $0.60.